Profiel
Ivan M.
Borrello is the founder of WindMIL Therapeutics, Inc. He is currently the Director at Cellular Therapeutics Ltd. Prior to this, he served as an Independent Director at Gamida Cell Ltd. from 2022 to 2024.
Dr. Borrello completed his undergraduate degree at The Catholic University of America and obtained his doctorate from the Medical College of Virginia.
Actieve functies van Ivan Borrello
| Bedrijven | Functie | Begin |
|---|---|---|
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Directeur/Bestuurslid | - |
Eerdere bekende functies van Ivan Borrello
| Bedrijven | Functie | Einde |
|---|---|---|
| GAMIDA CELL LTD. | Directeur/Bestuurslid | 24-05-2024 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Oprichter | - |
Opleiding van Ivan Borrello
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The Catholic University of America
The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Health Technology |
















